S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade
Apr 11 2022
Length: 23 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

Listen for free

View show details

Summary
In this episode, our faculty looks at the latest treatments for multiple sclerosis—the newest sphingosine-1-phosphate receptor modulators. What is their mechanism of action? Which patients would benefit from them, and how are side effects and toxicities managed with these latest treatment options?

Visit www.morningcommutepodcast.com/ms8 to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit

Show more Show less

Show more Show less

What listeners say about S2:E8 – Neurology Morning Commute: Multiple Sclerosis and the S1P Receptor Upgrade

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon